Tags

Type your tag names separated by a space and hit enter

Author Correction: Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1.
Nat Immunol. 2020 06; 21(6):695.NI

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Links

Publisher Full Text (DOI)

Authors+Show Affiliations

Crowther MD
Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.
Dolton G
Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.
Legut M
Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.
Caillaud ME
Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.
Lloyd A
Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.
Attaf M
Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.
Galloway SAE
Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.
Rius C
Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.
Farrell CP
Division of Hematology, University of Utah School of Medicine, Salt Lake City, UT, USA.
Szomolay B
Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK. Systems Immunity Research Institute, Cardiff University, Cardiff, UK.
Ager A
Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK. Systems Immunity Research Institute, Cardiff University, Cardiff, UK.
Parker AL
Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, UK.
Fuller A
Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.
Donia M
Center for Cancer Immune Therapy, Herlev Hospital, Copenhagen University, Copenhagen, Denmark.
McCluskey J
Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria, Australia.
Rossjohn J
Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK. Systems Immunity Research Institute, Cardiff University, Cardiff, UK. Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, Victoria, Australia. Infection and Immunity Program & Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
Svane IM
Center for Cancer Immune Therapy, Herlev Hospital, Copenhagen University, Copenhagen, Denmark.
Phillips JD
Division of Hematology, University of Utah School of Medicine, Salt Lake City, UT, USA.
Sewell AK
Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK. sewellak@cardiff.ac.uk. Systems Immunity Research Institute, Cardiff University, Cardiff, UK. sewellak@cardiff.ac.uk.

Pub Type(s)

Journal Article
Published Erratum

Language

eng

PubMed ID

32123375

Citation

Crowther, Michael D., et al. "Author Correction: Genome-wide CRISPR-Cas9 Screening Reveals Ubiquitous T Cell Cancer Targeting Via the Monomorphic MHC Class I-related Protein MR1." Nature Immunology, vol. 21, no. 6, 2020, p. 695.
Crowther MD, Dolton G, Legut M, et al. Author Correction: Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1. Nat Immunol. 2020;21(6):695.
Crowther, M. D., Dolton, G., Legut, M., Caillaud, M. E., Lloyd, A., Attaf, M., Galloway, S. A. E., Rius, C., Farrell, C. P., Szomolay, B., Ager, A., Parker, A. L., Fuller, A., Donia, M., McCluskey, J., Rossjohn, J., Svane, I. M., Phillips, J. D., & Sewell, A. K. (2020). Author Correction: Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1. Nature Immunology, 21(6), 695. https://doi.org/10.1038/s41590-020-0640-6
Crowther MD, et al. Author Correction: Genome-wide CRISPR-Cas9 Screening Reveals Ubiquitous T Cell Cancer Targeting Via the Monomorphic MHC Class I-related Protein MR1. Nat Immunol. 2020;21(6):695. PubMed PMID: 32123375.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Author Correction: Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1. AU - Crowther,Michael D, AU - Dolton,Garry, AU - Legut,Mateusz, AU - Caillaud,Marine E, AU - Lloyd,Angharad, AU - Attaf,Meriem, AU - Galloway,Sarah A E, AU - Rius,Cristina, AU - Farrell,Colin P, AU - Szomolay,Barbara, AU - Ager,Ann, AU - Parker,Alan L, AU - Fuller,Anna, AU - Donia,Marco, AU - McCluskey,James, AU - Rossjohn,Jamie, AU - Svane,Inge Marie, AU - Phillips,John D, AU - Sewell,Andrew K, PY - 2020/3/4/pubmed PY - 2020/3/4/medline PY - 2020/3/4/entrez SP - 695 EP - 695 JF - Nature immunology JO - Nat Immunol VL - 21 IS - 6 N2 - An amendment to this paper has been published and can be accessed via a link at the top of the paper. SN - 1529-2916 UR - https://www.unboundmedicine.com/medline/citation/32123375/Author_Correction:_Genome_wide_CRISPR_Cas9_screening_reveals_ubiquitous_T_cell_cancer_targeting_via_the_monomorphic_MHC_class_I_related_protein_MR1_ DB - PRIME DP - Unbound Medicine ER -